Ironwood Pharmaceuticals, Inc. /
VectivBio
Ironwood completes tender offer for VectivBio
- Price
- $1.15bn
- Stage
- Closed
What happened
Ironwood Pharmaceuticals, Inc. completed its tender offer for VectivBio Holding AG, a clinical-stage biopharmaceutical company developing treatments for severe rare gastrointestinal conditions.
The aggregate consideration was approximately $1.15 billion. The offer was $17.00 per share in cash.
The source
Everything on this page comes from the source below.
Ironwood completes tender offer for VectivBio
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly